Gazelle Parent, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Obsidian Therapeutics, Inc. (OBX) has filed an S-1 registration statement detailing its clinical-stage biopharmaceutical operations, focusing on its lead product candidate, amsoki-cel, for solid tumor treatments.